Skip to main navigation
Skip to search
Skip to main content
Research Profiles at Washington University School of Medicine Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
Gemcitabine combination chemotherapy of ovarian cancer.
David G. Mutch
Division of Gynecologic Oncology
Institute of Clinical and Translational Sciences
Siteman Cancer Center
Research output
:
Contribution to journal
›
Review article
›
peer-review
21
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Gemcitabine combination chemotherapy of ovarian cancer.'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
gemcitabine
100%
Combination Drug Therapy
90%
Ovarian Neoplasms
81%
Platinum Compounds
49%
Cytotoxins
25%
Paclitaxel
22%
Clinical Trials
14%
Salvage Therapy
13%
Carboplatin
12%
Cisplatin
10%
Therapeutics
7%